TickerFacts.

Company research / SOLV

Solventum Corp (SOLV)

Build a valuation ↗↓ Download CSV

CIK 0001964738 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Solventum Corp reported revenue of $8.32B. Revenue grew 0.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $8.31B.

Key ratios (year ended 2025-12-31)

53.5%
Gross margin
26.2%
Operating margin
18.7%
Net margin
30.8%
Return on year-end equity
0.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-03

Headquarters locality: Eagan · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-31
Revenue$8.31B$8.32B$8.25B$8.20B$8.13B
Gross Profit$4.54B$4.45B$4.59B$4.69B$4.70B
R&D Expense$725.00M$739.00M$775.00M$758.00M$767.00M
Operating Income$2.08B$2.18B$1.04B$1.69B$1.69B
Depreciation & Amortization$506.00M$489.00M$555.00M$561.00M$578.00M
EBITDA$2.58B$2.67B$1.59B$2.25B$2.27B
Net Income$1.43B$1.56B$479.00M$1.35B$1.34B
EPS (Diluted)n/a$8.88$2.76$7.79$7.78
Total Assets$14.24B$14.29B$14.46B$13.94Bn/a
Total Liabilities$9.44B$9.24B$11.50B$2.28Bn/a
Long-Term Debtn/a$5.04B$8.01B$0n/a
Shareholders' Equity$4.80B$5.05B$2.96B$11.67B$11.74B
Cash & Equivalents$403.00M$878.00M$762.00M$194.00Mn/a
Operating Cash Flow$209.00M$369.00M$1.19B$1.92B$1.68B
Capital Expenditures$327.00M$379.00M$380.00M$290.00M$251.00M
Free Cash Flow-$118.00M-$10.00M$805.00M$1.62B$1.43B
Shares Outstanding170.11M173.49M172.79Mn/an/a
Weighted Average Diluted Sharesn/a175.30M173.70M172.70M172.70M
EPS (Basic)n/a$8.94$2.77$7.79$7.78

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView